Norway· NO-ID_CA7237A2-ABC0-4EFE-BA28-AB1F7FF80A8E
Emgality
A galcanezumab product containing galcanezumab, registered in Norway by Eli Lilly Nederland B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Galcanezumab is registered in 13 of 19 countries.
Countries holding a registration under ATC N02CD02 (galcanezumab), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 9 of them publish a price we can compare per daily dose
Galcanezumab · ATC N02CD02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Galcanezumab
- Manufacturer
- Eli Lilly Nederland B.V.
- Country
- Norway (NO)
- ATC code
- N02CD02
- ATC class
- Galcanezumab
- Defined daily dose
- 4 mg, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_CA7237A2-ABC0-4EFE-BA28-AB1F7FF80A8E
- no_varenummer4688401NOK 5107.5
- gtin300020728558
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Galcanezumab in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEMGALITYEli Lilly Nederland B.V., Utrecht
- BelgiumEmgality 120 mgEli Lilly Nederland
- SpainEMGALITY 120 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAEli Lilly Nederland B.V.
- IcelandEmgalityEli Lilly Nederland B.V.*
- SwedenEmgality 120 mg Injektionsvätska, lösning i förfylld injektionspennaEli Lilly Nederland B.V.
- PolandEmgalityEli Lilly Nederland B.V.
- SwitzerlandEmgality 120 mg, solution injectable en stylo prérempliEli Lilly (Suisse) SA
- United KingdomEmgality 120mg/1ml solution for injection pre-filled pensOrganon Pharma (UK) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Emgality
- Liechtenstein · Emgality
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5b2200a6-ebde-4aca-9bdf-65fbb1db9a3e GET /v1/drugs/5b2200a6-ebde-4aca-9bdf-65fbb1db9a3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning i ferdigfylt penn",
"source": "fest",
"status": "A",
"atc_name": "Galkanezumab",
"merkevare_id": "ID_CA7237A2-ABC0-4EFE-BA28-AB1F7FF80A8E",
"name_form_strength": "Emgality inj, oppl 120 mg/penn",
"prescription_group": "C"
}See everything about galcanezumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.